Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Why Couche-Tard (TSX:ATD.B) Could Be the TSX Index’s Biggest Winner in the 2nd Half of 2019

Published 2019-07-15, 12:00 p/m
Updated 2019-07-15, 12:05 p/m
© Reuters.

Alimentation Couche-Tard (TSX:ATD.B) recently clocked in a slight Q4 FY 2019 earnings miss primarily due to temporary headwinds (unfavourable currency moves, poor weather, and fuel shortages in select regions, a rise in operating expenses, decreased demand for fuel, and the list goes on). Despite the miss, sentiment took a 180-degree turn when management shed light on its plan to double profitability in five years.

Yes, Couche-Tard is a big company, but it can and likely will meet its targets given management’s incredible track record of exceeding expectations of both investors and insiders.

Of course, there are exogenous factors that could derail the company’s “ambitious” long-term goal, such as a severe global recession happening within the next five years, but assuming the bull keeps roaring, I think Couche-Tard will have little problem meeting its goal ahead of time given the company has been firing on all cylinders, both organically (driving comps) and inorganically (driving synergies through accretive acquisitions).

Although sentiment turned positive in the day after Couche-Tard lifted the curtain on its mediocre quarter (which had remarkably strong comps), TD Securities slapped the stock with a downgrade to “hold” just days after the Q4 release, after having the opportunity to digest the results.

TD Securities is concerned with how frothy the valuation has become after its incredible rally, and while the stock does trade at the frothiest multiple it has in recent memory (26.2 times trailing earnings), I think the downgrade was unwarranted and that the stock has way more room to run, likely to $100 by year-end.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Yes, the valuation is a tad extended, but as David Gardner has always suggested, investors shouldn’t be afraid of seemingly expensive stocks that trade at or around their all-time highs.

David’s “Rule Breaker” approach to investing may scare some of the more value conscious of us, but when it comes to quality high-growth names like Couche-Tard, I firmly believe it’s more than “okay” to break the rules when it comes to name given any meaningful improvements made at the company-specific level.

My view?

Fundamental improvements warrant the multiple expansion in Couche-Tard shares.

I always thought Couche-Tard was worth around 30 times trailing earnings given the exceptional management team and the lower-risk growth profile. Now that the company is “killing it” on the comps front, I’m more confident in the name, as it pursues its next round of acquisitions.

Back in the day, when Couche-Tard pulled the trigger more frequently, the M&A announcements acted as fuel for the stock. Now that debt has fallen to reasonable levels, Couche-Tard has the ability to go on the hunt for its next takeover. The recent fuel for Couche-Tard’s stock has been about comps, and the next leg, I believe, will be about announced acquisitions and the potential for further synergies.

Yes, the stock isn’t “cheap” here on a historical valuation basis, but when you consider the potential for further multiple expansion and the likelihood of coming acquisitions (a catalyst for the stock), I’d say it’s a mistake to count Couche-Tard out just because the stock has a higher-than-historical-average P/E multiple.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Although it’d be nice to pick up shares on a pullback, it’s important to remember that it may not happen given the stock’s lower correlation to the broader markets. So, I have no problem encouraging investors to get some skin in the game today in spite of any recent analyst downgrades that cite valuation as the primary reason for concern.

Stay hungry. Stay Foolish.

Fool contributor Joey Frenette owns shares of ALIMENTATION COUCHE-TARD INC. Couche-Tard is a recommendation of Stock Advisor Canada.

The Motley Fool’s purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool Canada’s free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. Motley Fool Canada 2019

This Article Was First Published on The Motley Fool

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.